A Phase 1, Randomized, Double-blind, Placebo-controlled, Sequential-group, Multiple-dose, Drug-drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2010
At a glance
- Drugs Lomibuvir; Telaprevir
- Indications Hepatitis C
- Focus Adverse reactions
- 01 Mar 2010 Results have been reported in a Vertex Pharmaceuticals media release.
- 08 Jan 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 08 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov